comparemela.com
Home
Live Updates
MannKind Announces First Patient Enrolled In Inhale-1 Study Of Afrezza® In Pediatric Population : comparemela.com
MannKind Announces First Patient Enrolled In Inhale-1 Study Of Afrezza® In Pediatric Population
/PRNewswire/ -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients...
Related Keywords
United States
,
Brazil
,
Kevin Kaiserman
,
Michaelj Haller
,
Mannkind Corporation Nasdaq
,
University Of Florida
,
Diabetes Endocrinology Center
,
Exchange Commission
,
Mannkind Corporation
,
Safety Of Mannkind Corporation
,
Prnewswire Mannkind Corporation Nasdaq
,
Kind Corporation
,
Technosphere Insulin
,
Vice President
,
Medical Affairs
,
Endocrinology Center
,
Pediatric Endocrinology
,
Inhalation Powder
,
Westlake Village
,
Quarterly Report
,
comparemela.com © 2020. All Rights Reserved.